Zenas BioPharma, Inc. (ZBIO)
43.17
+0.36
(+0.84%)
USD |
NASDAQ |
Dec 24, 16:00
Zenas BioPharma Market Cap: 1.806B for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Royalty Pharma Plc | 16.77B |
| Nektar Therapeutics | 760.18M |
| Rigel Pharmaceuticals, Inc. | 810.27M |
| XOMA Royalty Corp. | 321.84M |
| Viridian Therapeutics, Inc. | 3.081B |
Market Cap Related Metrics
| PS Ratio | 120.60 |
| PEG Ratio | -0.2505 |
| Price to Book Value | 9.194 |
| Price | 43.17 |
| Earnings Yield | -10.50% |
| PEGY Ratio | -0.2505 |